NOX3_HUMAN
ID NOX3_HUMAN Reviewed; 568 AA.
AC Q9HBY0; Q9HBJ9;
DT 21-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT 01-MAR-2001, sequence version 1.
DT 03-AUG-2022, entry version 144.
DE RecName: Full=NADPH oxidase 3;
DE EC=1.6.3.-;
DE AltName: Full=Mitogenic oxidase 2;
DE Short=MOX-2;
DE AltName: Full=gp91phox homolog 3;
DE Short=GP91-3;
GN Name=NOX3; Synonyms=MOX2;
OS Homo sapiens (Human).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC Homo.
OX NCBI_TaxID=9606;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], AND DEVELOPMENTAL STAGE.
RC TISSUE=Fetal kidney;
RX PubMed=11376945; DOI=10.1016/s0378-1119(01)00449-8;
RA Cheng G., Cao Z., Xu X., van Meir E.G., Lambeth J.D.;
RT "Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and
RT Nox5.";
RL Gene 269:131-140(2001).
RN [2]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX PubMed=14574404; DOI=10.1038/nature02055;
RA Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA Rogers J., Beck S.;
RT "The DNA sequence and analysis of human chromosome 6.";
RL Nature 425:805-811(2003).
RN [3]
RP NUCLEOTIDE SEQUENCE [MRNA] OF 54-497, AND DEVELOPMENTAL STAGE.
RC TISSUE=Fetal kidney;
RX PubMed=10974555; DOI=10.1016/s0378-1119(00)00258-4;
RA Kikuchi H., Hikage M., Miyashita H., Fukumoto M.;
RT "NADPH oxidase subunit, gp91phox homologue, preferentially expressed in
RT human colon epithelial cells.";
RL Gene 254:237-243(2000).
RN [4]
RP ACTIVITY REGULATION.
RX PubMed=15181005; DOI=10.1074/jbc.m400660200;
RA Cheng G., Ritsick D., Lambeth J.D.;
RT "Nox3 regulation by NOXO1, p47phox, and p67phox.";
RL J. Biol. Chem. 279:34250-34255(2004).
RN [5]
RP FUNCTION, MUTAGENESIS OF PRO-413, ACTIVITY REGULATION, AND INTERACTION WITH
RP CYBA.
RX PubMed=15824103; DOI=10.1074/jbc.m414548200;
RA Ueno N., Takeya R., Miyano K., Kikuchi H., Sumimoto H.;
RT "The NADPH oxidase Nox3 constitutively produces superoxide in a p22phox-
RT dependent manner: its regulation by oxidase organizers and activators.";
RL J. Biol. Chem. 280:23328-23339(2005).
CC -!- FUNCTION: NADPH oxidase which constitutively produces superoxide upon
CC formation of a complex with CYBA/p22phox. Plays a role in the
CC biogenesis of otoconia/otolith, which are crystalline structures of the
CC inner ear involved in the perception of gravity.
CC {ECO:0000269|PubMed:15824103}.
CC -!- ACTIVITY REGULATION: Activated by the ototoxic drug cisplatin (By
CC similarity). Activated by NOXO1. Cooperatively activated by NCF1 and
CC NCF2 or NOXA1 in a phorbol 12-myristate 13-acetate (PMA)-dependent
CC manner. Inhibited by diphenyleneiodonium chloride. {ECO:0000250,
CC ECO:0000269|PubMed:15181005, ECO:0000269|PubMed:15824103}.
CC -!- SUBUNIT: Interacts with and stabilizes CYBA/p22phox.
CC {ECO:0000269|PubMed:15824103}.
CC -!- INTERACTION:
CC Q9HBY0; Q9BQA9: CYBC1; NbExp=3; IntAct=EBI-13069010, EBI-2680384;
CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC protein {ECO:0000305}.
CC -!- DEVELOPMENTAL STAGE: Expressed in fetal kidney and to a lower extent in
CC liver, lung and spleen. {ECO:0000269|PubMed:10974555,
CC ECO:0000269|PubMed:11376945}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AF190122; AAG17121.1; -; mRNA.
DR EMBL; AL031773; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR EMBL; AF229177; AAG15435.1; -; mRNA.
DR CCDS; CCDS5250.1; -.
DR RefSeq; NP_056533.1; NM_015718.2.
DR AlphaFoldDB; Q9HBY0; -.
DR SMR; Q9HBY0; -.
DR BioGRID; 119079; 1.
DR IntAct; Q9HBY0; 1.
DR STRING; 9606.ENSP00000159060; -.
DR ChEMBL; CHEMBL1741216; -.
DR PeroxiBase; 5960; HsNOx03.
DR TCDB; 5.B.1.1.4; the phagocyte (gp91(phox)) nadph oxidase family.
DR GlyGen; Q9HBY0; 2 sites.
DR iPTMnet; Q9HBY0; -.
DR PhosphoSitePlus; Q9HBY0; -.
DR BioMuta; NOX3; -.
DR DMDM; 74752785; -.
DR jPOST; Q9HBY0; -.
DR MassIVE; Q9HBY0; -.
DR PaxDb; Q9HBY0; -.
DR PeptideAtlas; Q9HBY0; -.
DR PRIDE; Q9HBY0; -.
DR ProteomicsDB; 81611; -.
DR Antibodypedia; 46722; 217 antibodies from 28 providers.
DR DNASU; 50508; -.
DR Ensembl; ENST00000159060.3; ENSP00000159060.2; ENSG00000074771.4.
DR GeneID; 50508; -.
DR KEGG; hsa:50508; -.
DR MANE-Select; ENST00000159060.3; ENSP00000159060.2; NM_015718.3; NP_056533.1.
DR UCSC; uc003qqm.4; human.
DR CTD; 50508; -.
DR DisGeNET; 50508; -.
DR GeneCards; NOX3; -.
DR HGNC; HGNC:7890; NOX3.
DR HPA; ENSG00000074771; Not detected.
DR MIM; 607105; gene.
DR neXtProt; NX_Q9HBY0; -.
DR OpenTargets; ENSG00000074771; -.
DR PharmGKB; PA31691; -.
DR VEuPathDB; HostDB:ENSG00000074771; -.
DR eggNOG; KOG0039; Eukaryota.
DR GeneTree; ENSGT00940000160501; -.
DR HOGENOM; CLU_005646_3_1_1; -.
DR InParanoid; Q9HBY0; -.
DR OMA; MCRLYSS; -.
DR OrthoDB; 936110at2759; -.
DR PhylomeDB; Q9HBY0; -.
DR TreeFam; TF105354; -.
DR PathwayCommons; Q9HBY0; -.
DR Reactome; R-HSA-5668599; RHO GTPases Activate NADPH Oxidases.
DR Reactome; R-HSA-9013149; RAC1 GTPase cycle.
DR Reactome; R-HSA-9013423; RAC3 GTPase cycle.
DR SignaLink; Q9HBY0; -.
DR SIGNOR; Q9HBY0; -.
DR BioGRID-ORCS; 50508; 12 hits in 1058 CRISPR screens.
DR GeneWiki; NOX3; -.
DR GenomeRNAi; 50508; -.
DR Pharos; Q9HBY0; Tbio.
DR PRO; PR:Q9HBY0; -.
DR Proteomes; UP000005640; Chromosome 6.
DR RNAct; Q9HBY0; protein.
DR Bgee; ENSG00000074771; Expressed in frontal cortex and 2 other tissues.
DR Genevisible; Q9HBY0; HS.
DR GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR GO; GO:0043020; C:NADPH oxidase complex; IBA:GO_Central.
DR GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR GO; GO:0016175; F:superoxide-generating NAD(P)H oxidase activity; IBA:GO_Central.
DR GO; GO:0006952; P:defense response; IBA:GO_Central.
DR GO; GO:0009590; P:detection of gravity; IEA:Ensembl.
DR GO; GO:0048840; P:otolith development; IEA:Ensembl.
DR GO; GO:0042554; P:superoxide anion generation; IBA:GO_Central.
DR GO; GO:0001659; P:temperature homeostasis; IEA:Ensembl.
DR Gene3D; 3.40.50.80; -; 1.
DR InterPro; IPR000778; Cyt_b245_heavy_chain.
DR InterPro; IPR013112; FAD-bd_8.
DR InterPro; IPR017927; FAD-bd_FR_type.
DR InterPro; IPR013130; Fe3_Rdtase_TM_dom.
DR InterPro; IPR013121; Fe_red_NAD-bd_6.
DR InterPro; IPR039261; FNR_nucleotide-bd.
DR InterPro; IPR029653; NOX3.
DR InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR PANTHER; PTHR11972:SF12; PTHR11972:SF12; 1.
DR Pfam; PF08022; FAD_binding_8; 1.
DR Pfam; PF01794; Ferric_reduct; 1.
DR Pfam; PF08030; NAD_binding_6; 1.
DR PRINTS; PR00466; GP91PHOX.
DR SUPFAM; SSF52343; SSF52343; 1.
DR SUPFAM; SSF63380; SSF63380; 1.
DR PROSITE; PS51384; FAD_FR; 1.
PE 1: Evidence at protein level;
KW Glycoprotein; Membrane; Oxidoreductase; Reference proteome; Transmembrane;
KW Transmembrane helix.
FT CHAIN 1..568
FT /note="NADPH oxidase 3"
FT /id="PRO_0000227596"
FT TOPO_DOM 1..13
FT /note="Cytoplasmic"
FT /evidence="ECO:0000255"
FT TRANSMEM 14..34
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 35..51
FT /note="Extracellular"
FT /evidence="ECO:0000255"
FT TRANSMEM 52..72
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 73..103
FT /note="Cytoplasmic"
FT /evidence="ECO:0000255"
FT TRANSMEM 104..124
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 125..167
FT /note="Extracellular"
FT /evidence="ECO:0000255"
FT TRANSMEM 168..188
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 189..201
FT /note="Cytoplasmic"
FT /evidence="ECO:0000255"
FT TRANSMEM 202..222
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 223..395
FT /note="Extracellular"
FT /evidence="ECO:0000255"
FT TRANSMEM 396..416
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 417..568
FT /note="Cytoplasmic"
FT /evidence="ECO:0000255"
FT DOMAIN 55..284
FT /note="Ferric oxidoreductase"
FT DOMAIN 285..395
FT /note="FAD-binding FR-type"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00716"
FT CARBOHYD 163
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 238
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT VARIANT 171
FT /note="T -> K (in dbSNP:rs3749930)"
FT /id="VAR_049103"
FT MUTAGEN 413
FT /note="P->H: Loss of catalytic activity."
FT /evidence="ECO:0000269|PubMed:15824103"
FT CONFLICT 328
FT /note="P -> S (in Ref. 3; AAG15435)"
FT /evidence="ECO:0000305"
SQ SEQUENCE 568 AA; 64935 MW; 10BCD6BEB18D0583 CRC64;
MMGCWILNEG LSTILVLSWL GINFYLFIDT FYWYEEEESF HYTRVILGST LAWARASALC
LNFNCMLILI PVSRNLISFI RGTSICCRGP WRRQLDKNLR FHKLVAYGIA VNATIHIVAH
FFNLERYHWS QSEEAQGLLA ALSKLGNTPN ESYLNPVRTF PTNTTTELLR TIAGVTGLVI
SLALVLIMTS STEFIRQASY ELFWYTHHVF IVFFLSLAIH GTGRIVRGQT QDSLSLHNIT
FCRDRYAEWQ TVAQCPVPQF SGKEPSAWKW ILGPVVLYAC ERIIRFWRFQ QEVVITKVVS
HPSGVLELHM KKRGFKMAPG QYILVQCPAI SSLEWHPFTL TSAPQEDFFS VHIRAAGDWT
AALLEAFGAE GQALQEPWSL PRLAVDGPFG TALTDVFHYP VCVCVAAGIG VTPFAALLKS
IWYKCSEAQT PLKLSKVYFY WICRDARAFE WFADLLLSLE TRMSEQGKTH FLSYHIFLTG
WDENQALHIA LHWDENTDVI TGLKQKTFYG RPNWNNEFKQ IAYNHPSSSI GVFFCGPKAL
SRTLQKMCHL YSSADPRGVH FYYNKESF
